ADVM

Adverum Biotechnologies (ADVM)

About Adverum Biotechnologies (ADVM)

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.

Details

Daily high

$7.85

Daily low

$7.44

Price at open

$7.65

52 Week High

$29.70

52 Week Low

$6.38

Market cap

160.8M

Dividend yield

0.00%

Volume

168,100

Avg. volume

242,542

P/E ratio

-.97

Adverum Biotechnologies News